Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer

Abstract This study aimed to characterize peak exercise cardiac function and thigh muscle fatty infiltration and their relationships with VO2peak among anthracycline-treated breast cancer survivors (BCS). BCS who received anthracycline chemotherapy ~ 1 year earlier (n = 16) and matched controls (mat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amy A. Kirkham, Mark J. Haykowsky, Rhys I. Beaudry, Justin G. Grenier, John R. Mackey, Edith Pituskin, D. Ian Paterson, Richard B. Thompson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3626ca8bdb784444a87d4760b0dbc993
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3626ca8bdb784444a87d4760b0dbc993
record_format dspace
spelling oai:doaj.org-article:3626ca8bdb784444a87d4760b0dbc9932021-12-02T15:22:56ZCardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer10.1038/s41598-021-93241-52045-2322https://doaj.org/article/3626ca8bdb784444a87d4760b0dbc9932021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93241-5https://doaj.org/toc/2045-2322Abstract This study aimed to characterize peak exercise cardiac function and thigh muscle fatty infiltration and their relationships with VO2peak among anthracycline-treated breast cancer survivors (BCS). BCS who received anthracycline chemotherapy ~ 1 year earlier (n = 16) and matched controls (matched-CON, n = 16) were enrolled. Resting and peak exercise cardiac function, myocardial T1 mapping (marker of fibrosis), and thigh muscle fat infiltration were assessed by magnetic resonance imaging, and VO2peak by cycle test. Compared to matched-CON, BCS had lower peak SV (64 ± 9 vs 57 ± 10 mL/m2, p = 0.038), GLS (− 30.4 ± 2.2 vs − 28.0 ± 2.5%, p = 0.008), and arteriovenous oxygen difference (16.4 ± 3.6 vs 15.2 ± 3.9 mL/100 mL, p = 0.054). Mediation analysis showed: (1) greater myocardial T1 time (fibrosis) is inversely related to cardiac output and end-systolic volume exercise reserve; (2) greater thigh muscle fatty infiltration is inversely related to arteriovenous oxygen difference; both of which negatively influence VO2peak. Peak SV (R2 = 65%) and thigh muscle fat fraction (R2 = 68%) were similarly strong independent predictors of VO2peak in BCS and matched-CON combined. Post-anthracyclines, myocardial fibrosis is associated with impaired cardiac reserve, and thigh muscle fatty infiltration is associated with impaired oxygen extraction, which both contribute to VO2peak.Amy A. KirkhamMark J. HaykowskyRhys I. BeaudryJustin G. GrenierJohn R. MackeyEdith PituskinD. Ian PatersonRichard B. ThompsonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Amy A. Kirkham
Mark J. Haykowsky
Rhys I. Beaudry
Justin G. Grenier
John R. Mackey
Edith Pituskin
D. Ian Paterson
Richard B. Thompson
Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
description Abstract This study aimed to characterize peak exercise cardiac function and thigh muscle fatty infiltration and their relationships with VO2peak among anthracycline-treated breast cancer survivors (BCS). BCS who received anthracycline chemotherapy ~ 1 year earlier (n = 16) and matched controls (matched-CON, n = 16) were enrolled. Resting and peak exercise cardiac function, myocardial T1 mapping (marker of fibrosis), and thigh muscle fat infiltration were assessed by magnetic resonance imaging, and VO2peak by cycle test. Compared to matched-CON, BCS had lower peak SV (64 ± 9 vs 57 ± 10 mL/m2, p = 0.038), GLS (− 30.4 ± 2.2 vs − 28.0 ± 2.5%, p = 0.008), and arteriovenous oxygen difference (16.4 ± 3.6 vs 15.2 ± 3.9 mL/100 mL, p = 0.054). Mediation analysis showed: (1) greater myocardial T1 time (fibrosis) is inversely related to cardiac output and end-systolic volume exercise reserve; (2) greater thigh muscle fatty infiltration is inversely related to arteriovenous oxygen difference; both of which negatively influence VO2peak. Peak SV (R2 = 65%) and thigh muscle fat fraction (R2 = 68%) were similarly strong independent predictors of VO2peak in BCS and matched-CON combined. Post-anthracyclines, myocardial fibrosis is associated with impaired cardiac reserve, and thigh muscle fatty infiltration is associated with impaired oxygen extraction, which both contribute to VO2peak.
format article
author Amy A. Kirkham
Mark J. Haykowsky
Rhys I. Beaudry
Justin G. Grenier
John R. Mackey
Edith Pituskin
D. Ian Paterson
Richard B. Thompson
author_facet Amy A. Kirkham
Mark J. Haykowsky
Rhys I. Beaudry
Justin G. Grenier
John R. Mackey
Edith Pituskin
D. Ian Paterson
Richard B. Thompson
author_sort Amy A. Kirkham
title Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
title_short Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
title_full Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
title_fullStr Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
title_full_unstemmed Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
title_sort cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3626ca8bdb784444a87d4760b0dbc993
work_keys_str_mv AT amyakirkham cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT markjhaykowsky cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT rhysibeaudry cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT justinggrenier cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT johnrmackey cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT edithpituskin cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT dianpaterson cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
AT richardbthompson cardiacandskeletalmusclepredictorsofimpairedcardiorespiratoryfitnesspostanthracyclinechemotherapyforbreastcancer
_version_ 1718387377221664768